These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 28460443)
1. Sphingosine-1-phosphate promotes ovarian cancer cell proliferation by disrupting Hippo signaling. Fan Q; Cheng Y; Chang HM; Deguchi M; Hsueh AJ; Leung PCK Oncotarget; 2017 Apr; 8(16):27166-27176. PubMed ID: 28460443 [TBL] [Abstract][Full Text] [Related]
2. CCN2 Mediates S1P-Induced Upregulation of COX2 Expression in Human Granulosa-Lutein Cells. Hu LL; Chang HM; Yi Y; Liu Y; Taylor EL; Zheng LP; Leung PCK Cells; 2019 Nov; 8(11):. PubMed ID: 31731760 [TBL] [Abstract][Full Text] [Related]
3. Actin polymerization-enhancing drugs promote ovarian follicle growth mediated by the Hippo signaling effector YAP. Cheng Y; Feng Y; Jansson L; Sato Y; Deguchi M; Kawamura K; Hsueh AJ FASEB J; 2015 Jun; 29(6):2423-30. PubMed ID: 25690654 [TBL] [Abstract][Full Text] [Related]
4. Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP. Miller E; Yang J; DeRan M; Wu C; Su AI; Bonamy GM; Liu J; Peters EC; Wu X Chem Biol; 2012 Aug; 19(8):955-62. PubMed ID: 22884261 [TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein-2 enhances gonadotropin-independent follicular development via sphingosine kinase 1. Ito M; Yoshino O; Ono Y; Yamaki-Ushijima A; Tanaka T; Shima T; Orisaka M; Iwase A; Nakashima A; Saito S Am J Reprod Immunol; 2021 May; 85(5):e13374. PubMed ID: 33175430 [TBL] [Abstract][Full Text] [Related]
7. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. Gery S; Xie D; Yin D; Gabra H; Miller C; Wang H; Scott D; Yi WS; Popoviciu ML; Said JW; Koeffler HP Clin Cancer Res; 2005 Oct; 11(20):7243-54. PubMed ID: 16243794 [TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-phosphate stimulated connective tissue growth factor expression in human buccal fibroblasts: Inhibition by epigallocatechin-3-gallate. Sar JI; Yang CJ; Tsai YS; Deng YT; Chen HM; Chang HH; Liu CM J Formos Med Assoc; 2015 Sep; 114(9):860-4. PubMed ID: 24035571 [TBL] [Abstract][Full Text] [Related]
10. Sphingosine 1-phosphate signaling through its receptor S1P Andrieu G; Ledoux A; Branka S; Bocquet M; Gilhodes J; Walzer T; Kasahara K; Inagaki M; Sabbadini RA; Cuvillier O; Hatzoglou A Sci Signal; 2017 Mar; 10(472):. PubMed ID: 28351953 [TBL] [Abstract][Full Text] [Related]
11. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells. Schwartz BM; Hong G; Morrison BH; Wu W; Baudhuin LM; Xiao YJ; Mok SC; Xu Y Gynecol Oncol; 2001 May; 81(2):291-300. PubMed ID: 11330965 [TBL] [Abstract][Full Text] [Related]
12. Effect of sphingosine-1-phosphate on activation of dormant follicles in murine and human ovarian tissue. Pors SE; Harðardóttir L; Olesen HØ; Riis ML; Jensen LB; Andersen AS; Cadenas J; Grønning AP; Colmorn LB; Dueholm M; Andersen CY; Kristensen SG Mol Hum Reprod; 2020 May; 26(5):301-311. PubMed ID: 32202615 [TBL] [Abstract][Full Text] [Related]
13. De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells. Berdyshev EV; Gorshkova IA; Usatyuk P; Zhao Y; Saatian B; Hubbard W; Natarajan V Cell Signal; 2006 Oct; 18(10):1779-92. PubMed ID: 16529909 [TBL] [Abstract][Full Text] [Related]
14. Sphingosine 1-phosphate: a potential molecular target for ovarian cancer therapy? Dai L; Xia P; Di W Cancer Invest; 2014 Mar; 32(3):71-80. PubMed ID: 24499107 [TBL] [Abstract][Full Text] [Related]
15. Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation. Kang YC; Kim KM; Lee KS; Namkoong S; Lee SJ; Han JA; Jeoung D; Ha KS; Kwon YG; Kim YM Cell Death Differ; 2004 Dec; 11(12):1287-98. PubMed ID: 15297884 [TBL] [Abstract][Full Text] [Related]
16. Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye. Swaney JS; Moreno KM; Gentile AM; Sabbadini RA; Stoller GL Exp Eye Res; 2008 Oct; 87(4):367-75. PubMed ID: 18687328 [TBL] [Abstract][Full Text] [Related]
17. Cell-intrinsic PD-1 promotes proliferation in pancreatic cancer by targeting CYR61/CTGF via the hippo pathway. Pu N; Gao S; Yin H; Li JA; Wu W; Fang Y; Zhang L; Rong Y; Xu X; Wang D; Kuang T; Jin D; Yu J; Lou W Cancer Lett; 2019 Sep; 460():42-53. PubMed ID: 31233838 [TBL] [Abstract][Full Text] [Related]
18. The sphingomyelin/ceramide pathway is involved in ERK1/2 phosphorylation, cell proliferation, and uPAR overexpression induced by tissue-type plasminogen activator. Maupas-Schwalm F; Augé N; Robinet C; Cambus JP; Parsons SJ; Salvayre R; Nègre-Salvayre A FASEB J; 2004 Sep; 18(12):1398-400. PubMed ID: 15231724 [TBL] [Abstract][Full Text] [Related]
19. CD44 acts through RhoA to regulate YAP signaling. Zhang Y; Xia H; Ge X; Chen Q; Yuan D; Chen Q; Leng W; Chen L; Tang Q; Bi F Cell Signal; 2014 Nov; 26(11):2504-13. PubMed ID: 25101858 [TBL] [Abstract][Full Text] [Related]
20. Evaluating the antitumor activity of sphingosine-1-phosphate against human triple-negative breast cancer cells with basal-like morphology. Abuhussein O; Yang J Invest New Drugs; 2020 Oct; 38(5):1316-1325. PubMed ID: 32060788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]